Weed (BUDZ) Profit After Tax Growth (3y) (2020 - 2026)
Weed (BUDZ) Profit After Tax Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn | 14.01% |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.89% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 8.71% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -34.81% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 15.37% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 36.74% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Weed | 2.88 Mn | 2.88 Mn | - | 15.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.84% |
| Dec 31, 2025 | 4.30% |
| Sep 30, 2025 | 37.87% |
| Jun 30, 2025 | -35.19% |
| Mar 31, 2025 | 9.34% |
| Dec 31, 2024 | 34.26% |
| Sep 30, 2024 | 17.86% |
| Jun 30, 2024 | 55.12% |
| Mar 31, 2024 | 44.01% |
| Dec 31, 2023 | -24.07% |
| Sep 30, 2023 | 83.28% |
| Jun 30, 2023 | 33.27% |
| Mar 31, 2023 | 60.10% |
| Dec 31, 2022 | 33.61% |
| Sep 30, 2022 | 63.40% |
| Jun 30, 2022 | 26.66% |
| Mar 31, 2022 | 62.42% |
| Dec 31, 2021 | 59.70% |
| Sep 30, 2021 | 71.29% |
| Jun 30, 2021 | 49.24% |